PDCD1 and Hodgkins lymphoma: Given the impressive therapeutic response to PD-1 antibodies recently reported in HL [7,8], an overview of IE pathways and characterization of immune cells distribution in HL is helpful for understanding the process of immune restoration and thus predicting immune therapy strategy responses.